Update on acquisition of new ordinary shares of Vinpai SA pursuant to conversion of convertible bonds
As filed · Camlin Fine Sciences Limited has informed the Exchange about Update on acquisition of new ordinary shares of Vinpai SA pursuant to conversion of convertible bonds.
What happened
FactCamlin Fine Sciences Limited has informed the Exchange about Update on acquisition of new ordinary shares of Vinpai SA pursuant to conversion of convertible bonds. acquisition of 27,23,316 ordinary shares i.e. 78.68% of Vinpai’s share capital on a preferential basis.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedWe feel that in this quarter, the second quarter itself, we will have a positive EBITDA in Aroma.
We feel that now the margin should be in the range of 10% to 12% this year.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- To answer your question on next year, FY'27, the gross margin should improve by at least a couple of percent w (management committed by FY27)
- For FY'27, we have both methyl Vanillin and ethyl Vanillin and our guidance for FY'27 is between the two, the (management committed by FY27)
Evidence
- Camlin Fine Sciences Limited has informed the Exchange about Update on acquisition of new ordinary shares of Vinpai SA pursuant to conversion of convertible bonds.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- ACQUISITION base 74; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%